Prosecution Insights
Last updated: April 19, 2026
Application No. 18/520,086

BLOOD PUMPS

Non-Final OA §102§DP
Filed
Nov 27, 2023
Examiner
MORALES, JON ERIC C
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Procyrion Inc.
OA Round
5 (Non-Final)
85%
Grant Probability
Favorable
5-6
OA Rounds
2y 10m
To Grant
95%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allow Rate
1057 granted / 1238 resolved
+15.4% vs TC avg
Moderate +10% lift
Without
With
+9.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
39 currently pending
Career history
1277
Total Applications
across all art units

Statute-Specific Performance

§101
3.8%
-36.2% vs TC avg
§103
34.1%
-5.9% vs TC avg
§102
34.7%
-5.3% vs TC avg
§112
6.6%
-33.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1238 resolved cases

Office Action

§102 §DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 2-3, 6-7, and 21-22 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Heuring et al. (US 20140128659), cited previously. Regarding claim 2, Heuring discloses a blood flow assist system (Abstract) comprising: a pump 80, 82, 110 configured for percutaneous insertion to a treatment location of a patient (section 0098); the pump 82 comprising a motor housing 90 (Fig. 27a), the motor housing comprising, a retrieval feature (#3 arrow in Fig. 27A shown below, Section 0202, The devices power wire and a snare wire extend from the end of the device, through and past the end of the obturator. The snare wire is enclosed on the retrieval hook or slot at the end of the device. the retrieval process could be followed if retrieval or repositioning is needed) disposed at a proximal portion (end indicated by arrow 2 in Fig. 27A shown below) of the motor housing 90; and an elongate body (indicated by arrow 1 in fig. 27A) extending proximally from the pump, the elongate body disposed proximal the motor housing (Fig. 27A, section 0100, A power wire is associated with motor, and as will hereinafter described in greater detail, it extends from intravascular pumping module to a point at which it may be associated with a power source, such as a battery); PNG media_image1.png 203 626 media_image1.png Greyscale Regarding claim 3, Heuring discloses the enlarged diameter section 248 comprises a first curved portion having a first radius of curvature and a second curved portion having a second radius of curvature different from the first radius of curvature (Fig. 26D, section 0158). Regarding claim 6, a proximal portion of the motor housing comprises the proximal curved portion (Fig 26D, section 0158). Regarding claim 7, the pump comprises a pump housing 82 and an impeller 94 in the pump housing, and wherein the motor housing includes a motor 90 operably coupled with the impeller (Figs. 9-10). Regarding claim 21, Heuring discloses wherein the motor housing comprises a retrieval feature 117 between a proximal curved portion (#3 arrow in Fig. 27A shown below, Section 0202) of the pump and the elongate body, the retrieval feature comprising an enlarged diameter section (#1 arrow in Fig. 27A shown below) and a neck (#2 arrow in Fig. 27A shown below) between the enlarged diameter section and the proximal curved portion of the pump (Fig. 27A, Section 0202, The snare wire is enclosed on the retrieval hook or slot at the end of the device). PNG media_image1.png 203 626 media_image1.png Greyscale Regarding claim 22, the enlarged diameter section ((#1 arrow in Fig. 27A shown above) is wider than the neck (#2 arrow in Fig. 27A shown above). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claim 4 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 18 of U.S. Patent No. 11517736, cited previously. Although the claims at issue are not identical, they are not patentably distinct from each other because both claim a first and second curved portion with an angle different than the first curved portion as stated in the specification (column 10 lines 55-60). Allowable Subject Matter Claims 5 and 8 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claims 9-20 are allowed. The following is a statement of reasons for the indication of allowable subject matter: Regarding independent claim 9, for a blood flow assist system comprising the retrieval feature comprising an enlarged diameter section and a neck between the enlarged diameter section and the proximal curved portion of the pump, wherein the enlarged diameter section comprises a plurality of lobes extending radially outward has not been suggested or disclosed in the prior art when combined with the rest of the claim limitations of independent claim 9. Regarding independent claim 15, for a blood flow assist system comprising the retrieval feature comprising an enlarged diameter section and a neck between the enlarged diameter section and the proximal curved portion of the pump, wherein the neck comprises a first depth at a first circumferential position of the retrieval feature and a second depth less than the first depth at a second circumferential position of the retrieval feature spaced apart from the first circumferential position has not been suggested or disclosed in the prior art when combined with the rest of the claim limitations of independent claim 15. Response to Arguments Applicant's arguments filed 11/24/2025 have been fully considered but they are not persuasive. Examiner finds that Heuring discloses the motor housing comprising, a retrieval feature 3 arrow in Fig. 27A shown below, Section 0202, The devices power wire and a snare wire extend from the end of the device, through and past the end of the obturator. The snare wire is enclosed on the retrieval hook or slot at the end of the device. the retrieval process could be followed if retrieval or repositioning is needed) disposed at a proximal portion (end indicated by arrow 2 in Fig. 27A shown below) of the motor housing 90; and an elongate body (indicated by arrow 1 in fig. 27A) extending proximally from the pump, the elongate body disposed proximal the motor housing (Fig. 27A, section 0100, A power wire is associated with motor, and as will hereinafter described in greater detail, it extends from intravascular pumping module to a point at which it may be associated with a power source, such as a battery); PNG media_image1.png 203 626 media_image1.png Greyscale Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JON ERIC C MORALES whose telephone number is (571)272-3107. The examiner can normally be reached Monday-Friday 830AM-530PM CST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JON ERIC C MORALES/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Nov 27, 2023
Application Filed
Apr 01, 2024
Response after Non-Final Action
Jun 24, 2024
Non-Final Rejection — §102, §DP
Oct 28, 2024
Response Filed
Dec 05, 2024
Final Rejection — §102, §DP
Apr 10, 2025
Request for Continued Examination
Apr 14, 2025
Response after Non-Final Action
Apr 16, 2025
Non-Final Rejection — §102, §DP
Jul 21, 2025
Response Filed
Aug 20, 2025
Final Rejection — §102, §DP
Nov 24, 2025
Request for Continued Examination
Dec 04, 2025
Response after Non-Final Action
Dec 11, 2025
Non-Final Rejection — §102, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599349
DETERMINING A THERAPY EFFICACY
2y 5m to grant Granted Apr 14, 2026
Patent 12594417
SYSTEMS AND METHODS FOR SIMULATING CARDIOVASCULAR FLUID FLOW
2y 5m to grant Granted Apr 07, 2026
Patent 12588831
METHOD FOR MONITORING LUNG INTEGRITY
2y 5m to grant Granted Mar 31, 2026
Patent 12589237
MECHANICAL CIRCULATORY SUPPORT SYSTEM WITH GUIDEWIRE AID
2y 5m to grant Granted Mar 31, 2026
Patent 12589235
FLEXIBLE OUTFLOW CANNULA WITH SHAPED OUTLETS
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
85%
Grant Probability
95%
With Interview (+9.8%)
2y 10m
Median Time to Grant
High
PTA Risk
Based on 1238 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month